BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 16979568)

  • 1. Complex modulation of cell type-specific signaling in response to type I interferons.
    van Boxel-Dezaire AH; Rani MR; Stark GR
    Immunity; 2006 Sep; 25(3):361-72. PubMed ID: 16979568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of type I interferon signaling in normal and malignant cells.
    Li Y; Srivastava KK; Platanias LC
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT activation and differential complex formation dictate selectivity of interferon responses.
    Wesoly J; Szweykowska-Kulinska Z; Bluyssen HA
    Acta Biochim Pol; 2007; 54(1):27-38. PubMed ID: 17351669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases.
    Grote K; Luchtefeld M; Schieffer B
    Vascul Pharmacol; 2005 Nov; 43(5):357-63. PubMed ID: 16271517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus tyrosine kinases and signal transducers and activators of transcription regulate critical functions of T cells in allograft rejection and transplantation tolerance.
    Stepkowski SM; Kirken RA
    Transplantation; 2006 Aug; 82(3):295-303. PubMed ID: 16906023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.
    Lau JF; Horvath CM
    Mt Sinai J Med; 2002 May; 69(3):156-68. PubMed ID: 12035075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel type-1 cytokine receptor from fish involved in the Janus kinase/signal transducers and activators of transcription (Jak/STAT) signal pathway.
    Santos MD; Yasuike M; Kondo H; Hirono I; Aoki T
    Mol Immunol; 2007 Jul; 44(13):3355-63. PubMed ID: 17383728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of unphosphorylated STATs in signaling.
    Yang J; Stark GR
    Cell Res; 2008 Apr; 18(4):443-51. PubMed ID: 18364677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway.
    Du Z; Wei L; Murti A; Pfeffer SR; Fan M; Yang CH; Pfeffer LM
    J Cell Biochem; 2007 Dec; 102(5):1087-94. PubMed ID: 17910035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type-specific signaling in response to interferon-gamma.
    van Boxel-Dezaire AH; Stark GR
    Curr Top Microbiol Immunol; 2007; 316():119-54. PubMed ID: 17969446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropy and redundancy of STAT proteins in early pregnancy.
    Maj T; Chelmonska-Soyta A
    Reprod Domest Anim; 2007 Aug; 42(4):343-53. PubMed ID: 17635769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of T cell homeostasis by JAKs and STATs.
    Ross JA; Nagy ZS; Cheng H; Stepkowski SM; Kirken RA
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):231-45. PubMed ID: 17659375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases.
    Zhou Z; Hamming OJ; Ank N; Paludan SR; Nielsen AL; Hartmann R
    J Virol; 2007 Jul; 81(14):7749-58. PubMed ID: 17507495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines.
    Samaan A; Mahana W
    Immunol Lett; 2007 Apr; 109(2):113-9. PubMed ID: 17368812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukins and STAT signaling.
    Haque SJ; Sharma P
    Vitam Horm; 2006; 74():165-206. PubMed ID: 17027515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
    O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
    Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2.
    Wang F; Barrett JW; Shao Q; Gao X; Dekaban GA; McFadden G
    Virology; 2009 Apr; 387(1):136-46. PubMed ID: 19254804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of type-I- and type-II-interferon-mediated signalling.
    Platanias LC
    Nat Rev Immunol; 2005 May; 5(5):375-86. PubMed ID: 15864272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT-mediated EGFR signaling in cancer.
    Quesnelle KM; Boehm AL; Grandis JR
    J Cell Biochem; 2007 Oct; 102(2):311-9. PubMed ID: 17661350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.